• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The role of uncertainty regarding the results of screening immunoassays in blood establishments.

作者信息

Pereira Paulo, Westgard James O, Encarnação Pedro, Seghatchian Jerard, de Sousa Gracinda

机构信息

Department of Quality Assurance, Portuguese Institute of Blood and Transplantation, Avenida Miguel Bombarda 6, 1000-208 Lisboa, Portugal.

Department of Pathology and Laboratory Medicine, University of Wisconsin Medical School, Madison, WI, USA.

出版信息

Transfus Apher Sci. 2015 Apr;52(2):252-5. doi: 10.1016/j.transci.2015.02.015. Epub 2015 Feb 14.

DOI:10.1016/j.transci.2015.02.015
PMID:25754470
Abstract

The risk of uncertain results in infectious agents' tests is recognized in blood establishments, being particularly evident during the blood donor selection. The current risk-based approaches require risk assessment and "risk-based thinking". Accordingly, the blood establishment should consider the effect of uncertainty in all the technical decisions taken in a screening laboratory. Since the post-transfusion safety is one of the blood establishments' goals, the risk of post-transfusion infection should be evaluated and actions taken to decrease the chance of blood donations validation use false negative results. This article reviews and discusses the sources of uncertainty of infectious agents' reported results in blood establishments. It describes a set of sources of uncertainty that should be considered in screening immunoassay's decisions. The infectious agents' uncertainty concern is critical for reporting reliable results.

摘要

相似文献

1
The role of uncertainty regarding the results of screening immunoassays in blood establishments.
Transfus Apher Sci. 2015 Apr;52(2):252-5. doi: 10.1016/j.transci.2015.02.015. Epub 2015 Feb 14.
2
Scheme for the selection of measurement uncertainty models in blood establishments' screening immunoassays.血液机构筛查免疫测定中测量不确定度模型的选择方案。
Transfus Apher Sci. 2015 Feb;52(1):42-7. doi: 10.1016/j.transci.2014.12.018. Epub 2014 Dec 29.
3
Evaluation of the measurement uncertainty in screening immunoassays in blood establishments: computation of diagnostic accuracy models.血液机构中筛查免疫测定的测量不确定度评估:诊断准确性模型的计算
Transfus Apher Sci. 2015 Feb;52(1):35-41. doi: 10.1016/j.transci.2014.12.017. Epub 2015 Jan 6.
4
Quality management in European screening laboratories in blood establishments: A view of current approaches and trends.欧洲血液机构筛查实验室的质量管理:当前方法与趋势概览
Transfus Apher Sci. 2015 Apr;52(2):245-51. doi: 10.1016/j.transci.2015.02.014. Epub 2015 Feb 14.
5
Analytical model for calculating indeterminate results interval of screening tests, the effect on seroconversion window period: a brief evaluation of the impact of uncertain results on the blood establishment budget.计算筛查试验不确定结果区间的分析模型、对血清转化窗口期的影响:对不确定结果对血库预算影响的简要评估
Transfus Apher Sci. 2014 Oct;51(2):126-31. doi: 10.1016/j.transci.2014.10.004.
6
Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.用于输血或进一步制造用途的血液及血液成分要求。最终规则。
Fed Regist. 2015 May 22;80(99):29841-906.
7
In the NAT era, is routine lookback to recipients still required when donors seroconvert for HIV infection?在核酸检测时代,当供者发生HIV感染血清阳转时,是否仍需要对受者进行常规追溯?
Vox Sang. 2019 May;114(4):394-396. doi: 10.1111/vox.12767. Epub 2019 Feb 28.
8
The revision of the European blood directives: A major challenge for transfusion medicine.欧洲血液指令的修订:输血医学面临的一项重大挑战。
Transfus Clin Biol. 2015 Aug;22(3):141-7. doi: 10.1016/j.tracli.2015.05.003. Epub 2015 Jun 6.
9
[Blood transfusion and supply chain management safety].[输血与供应链管理安全]
Presse Med. 2015 Feb;44(2):214-20. doi: 10.1016/j.lpm.2014.06.036. Epub 2015 Jan 8.
10
Alternative strategies in assuring blood safety: An overview.确保血液安全的替代策略:概述
Biologicals. 2010 Jan;38(1):31-5. doi: 10.1016/j.biologicals.2009.10.009. Epub 2010 Jan 27.

引用本文的文献

1
The impact of grey zones on the accuracy of agreement measures for ordinal tables.灰区对有序表一致性度量准确性的影响。
BMC Med Res Methodol. 2021 Apr 14;21(1):70. doi: 10.1186/s12874-021-01248-3.
2
Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety: Experience at a tertiary care hospital in North India.酶联免疫吸附试验检测灰色地带样本对提高血液安全性的影响:印度北部一家三级护理医院的经验
Asian J Transfus Sci. 2016 Jan-Jun;10(1):71-4. doi: 10.4103/0973-6247.164272.